Citizen, Fossil develop wristwatch able to receive data

Citizen, Fossil develop wristwatch able to receive data

TOKYO, Japan - Citizen Watch Co. and U.S. watchmaker Fossil Inc. have started production of Wrist Net (shown) -- a wristwatch jointly developed by the two companies for the North American market and capable of receiving news, weather and other information, the Japanese watchmaker said Jan. 21.

  • Product Code
  • ILEA001100912
  • Registered date
  • 2004/1/21 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2004 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 230.72(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    Sompo CEO to step down over Bigmotor insurance fraud scandal

    TOKYO, Japan, Jan. 26 Kyodo - Major Japanese insurance firm Sompo Holdings Inc. CEO Kengo Sakurada holds a press conference in Tokyo on Jan. 26, 2024, to announce he will step down at the end of March to take responsibility for the company's involvement in used car dealer Bigmotor Co.'s insurance fraud scandal. (Kyodo)
      Press conference by Japan's SBI, Taiwan's PSMC

      Press conference by Japan's SBI, Taiwan's PSMC

      Yoshitaka Kitao (L), chairman and president of Japanese financial group SBI Holdings Inc., and Frank Huang, chairman of Taiwan's Powerchip Semiconductor Manufacturing Corp., attend a press conference in Tokyo on Oct. 31, 2023. The two companies said they have selected the village of Ohira in Miyagi Prefecture, northeastern Japan, as the location for their planned joint chip factory.
        Press conference by Japan's SBI, Taiwan's PSMC

        Press conference by Japan's SBI, Taiwan's PSMC

        Yoshitaka Kitao (L), chairman and president of Japanese financial group SBI Holdings Inc., and Frank Huang, chairman of Taiwan's Powerchip Semiconductor Manufacturing Corp., shake hands at a press conference in Tokyo on Oct. 31, 2023. The two companies said they have selected the village of Ohira in Miyagi Prefecture, northeastern Japan, as the location for their planned joint chip factory.
          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
            U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

            U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

            Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                EV maker BYD's entry into Japan market

                EV maker BYD's entry into Japan market

                The Japanese unit of Chinese electric vehicle maker BYD Co. holds a press event in Tokyo on July 21, 2022, to announce its entry into the Japanese vehicle market.
                  Joint Conference by SOMPO Holdings and Palantir Technologies

                  Joint Conference by SOMPO Holdings and Palantir Technologies

                  Palantir Technologies (California) , a U.S. provider of big data analysis, announced on the 18th that it has established a joint venture with SOMPO Holdings (HD) (photo). On December 1, Palantir will provide a service to analyze all kinds of data within Japanese companies and public institutions, including Excel, e-mail, and call records. The data will be used to predict the possibility of free recalls of automobile parts and to detect money laundering. The new company, Palantir Technologies Japan (Chuo Ward, Tokyo), is 50% owned by Palantir and 50% by SOMPOHD. It will be capitalized at 100 million dollars (about 10.8 billion yen), and aims to achieve sales of 100 billion yen in the medium to long term. President Kengo Sakurada expressed his hope that the company will pursue its dream of becoming a real data platformer. Photo taken on November 18, 2019, credit: Nikkan Kogyo Shimbun / Kyodo News Images
                    Record companies eye new businesses as CD sales dwindle

                    Record companies eye new businesses as CD sales dwindle

                    TOKYO, japan - Comedian Hikaru Tanaka (L) hands an autographed copy of his comic "Dr. Nakajima's World Conquest," published by Pony Canyon Inc., to a fan during a book-signing event outside a bookstore in Tokyo on Dec. 21, 2014. Amid shrinking sales of CDs, Pony Canyon and other Japanese record companies are diversifying into all sorts of other fields in search of new business opportunities.
                      Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

                      Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

                      TOKYO, Japan - Tatsuo Higuchi, president of Otsuka Holdings Co., attends a press conference in Tokyo's Minato Ward on Dec. 2, 2014, on the planned acquisition by its subsidiary Otsuka Pharmaceutical Co. of California-based biopharmaceutical firm Avanir Pharmaceuticals Inc. for $3.54 billion through a tender offer to be followed by a merger. The Japanese nutrition product and drug manufacturer will pay $17 per Avanir share in the takeover bid through its U.S. subsidiary.